Quince Therapeutics Newsroom

Brookline Capital Initiates Quince Therapeutics(QNCX.US) With Buy Rating, Announces Target Price $9

Moomoo NewsDec 19 05:34 ET

Brookline Capital Initiates Coverage On Quince Therapeutics With Buy Rating, Announces Price Target of $9

BenzingaDec 18 07:49 ET

Quince Therapeutics Analyst Ratings

BenzingaDec 18 07:48 ET

Maxim Group Maintains Quince Therapeutics(QNCX.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsNov 15 15:31 ET

Maxim Group Maintains Quince Therapeutics(QNCX.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsNov 13 08:32 ET

Promising Potential of EryDex: Jason McCarthy's Buy Rating for Quince Therapeutics

TipRanksNov 13 08:18 ET

D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $12 Price Target

BenzingaNov 12 12:40 ET

Maxim Group Initiates Quince Therapeutics(QNCX.US) With Buy Rating, Announces Target Price $6

Moomoo NewsNov 7 08:39 ET

Quince Therapeutics Initiated at Buy by Rodman & Renshaw

Dow JonesOct 29 07:45 ET

Quince Therapeutics Price Target Announced at $11.00/Share by Rodman & Renshaw

Dow JonesOct 29 07:45 ET

Quince Therapeutics Analyst Ratings

BenzingaOct 22 07:15 ET